Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
April 18 Product: Genentechs Alecensa Indication: Non-small cell lung cancer The FDA approved Genentechs Alecensa Thursday as the first adjuvant treatment for patients with early-stage, anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer who have undergone tumor resection
All the people under 30 I spoke to for this article know how dangerous tanning is
At Set Point Medical Weight Loss Clinic, our ultimate goal is to support you in achieving sustainable weight loss and improving your overall quality of life
It can lead to excessive hair growth and even male pattern baldness
US$ 22.42
US$ 26.30
US$ 21.61
US$ 24.24
